News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEvents
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

A. MARK FENDRICK & DAN KLEIN

Advertisement

Articles by A. MARK FENDRICK & DAN KLEIN

The Administration's Drug Rebate Proposal: An Opportunity to Put Patients First

ByA. MARK FENDRICK & DAN KLEIN
February 26th 2019
Advertisement

Latest Updated Articles

  • The Administration's Drug Rebate Proposal: An Opportunity to Put Patients First
    The Administration's Drug Rebate Proposal: An Opportunity to Put Patients First

    Published: February 26th 2019 | Updated:



Advertisement
Advertisement

Trending on Oncology Nursing News

1

T-DXd/Pertuzumab Combo Earns FDA Approval in Advanced HER2+ Breast Cancer

2

FDA Greenlights Niraparib/Abiraterone Acetate With Prednisone in mHSPC

3

Pembrolizumab Plus RT Ups T-Cell Infiltration in Early Breast Cancer

4

Teclistamab/Daratumumab Increases OS, PFS in R/R Multiple Myeloma

5

Oral Azacitidine Yields Similar PK to Subcutaneous Azacitidine in MDS/CMML

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us